Sign in

NCT07591701Recruiting

Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

Source: ClinicalTrials.gov · Last updated 26 Jun 2026

Brief summary (registry, in English)

The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
29 Dec 2025
Start date
26 May 2026
Primary completion date
31 Jan 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT07591701

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 26 May 2026 to the primary completion date, 31 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • These criteria include prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition or have a medical condition that prevents participation in the trial.

Who the study is looking for

  • These criteria include diagnosed prostate cancer patients receiving care at LBJ Hospital who
  • Are eligible for an open prostate cancer clinical trial at LBJ Hospital during the study period
  • Can provide informed consent.

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
The University of Texas M. D. Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.